Trial · NCT02688647
Results by group375
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 375
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Efficacy: Mean Changes in FVC From Baseline to Week 24 | Belumosudil-R | Baseline | 2608.2 | Standard Deviation 829.6 | mL |
| Efficacy: Mean Changes in FVC From Baseline to Week 24 | BSC-R | Baseline | 2516.7 | Standard Deviation 741.8 | mL |
| Efficacy: Mean Changes in FVC From Baseline to Week 24 | Belumosudil-WC | Baseline | 2608.8 | Standard Deviation 840.4 | mL |
| Efficacy: Mean Changes in FVC From Baseline to Week 24 | BSC-NC | Baseline | 2516.7 | Standard Deviation 741.8 | mL |
| Efficacy: Mean Changes in FVC From Baseline to Week 24 | Total | Baseline | 2569.3 | Standard Deviation 794.3 | mL |
| Efficacy: Mean Changes in FVC From Baseline to Week 24 | Belumosudil-R | At Week 24 | 2626.8 | Standard Deviation 886.9 | mL |
| Efficacy: Mean Changes in FVC From Baseline to Week 24 | BSC-R | At Week 24 | 2438.1 | Standard Deviation 757.1 | mL |
| Efficacy: Mean Changes in FVC From Baseline to Week 24 | Belumosudil-WC | At Week 24 | 2617.4 | Standard Deviation 890.8 | mL |
| Efficacy: Mean Changes in FVC From Baseline to Week 24 | BSC-NC | At Week 24 | 2436.8 | Standard Deviation 784.5 | mL |
| Efficacy: Mean Changes in FVC From Baseline to Week 24 | Total | At Week 24 | 2533.7 | Standard Deviation 832.7 | mL |
| Efficacy: Mean Changes in FVC From Baseline to Week 24 | Belumosudil-R | Change at Week 24 | -115.8 | Standard Deviation 330.3 | mL |
| Efficacy: Mean Changes in FVC From Baseline to Week 24 | BSC-R | Change at Week 24 | -71.2 | Standard Deviation 254.2 | mL |
| Efficacy: Mean Changes in FVC From Baseline to Week 24 | Belumosudil-WC | Change at Week 24 | -110.8 | Standard Deviation 316.4 | mL |
| Efficacy: Mean Changes in FVC From Baseline to Week 24 | BSC-NC | Change at Week 24 | -103.4 | Standard Deviation 225.0 | mL |
| Efficacy: Mean Changes in FVC From Baseline to Week 24 | Total | Change at Week 24 | -99.5 | Standard Deviation 281.4 | mL |
| Efficacy: Mean Changes in FVC% Predicted From Baseline at Week 24 | Belumosudil-R | Baseline | 69.61 | Standard Deviation 18.07 | % of predicted |
| Efficacy: Mean Changes in FVC% Predicted From Baseline at Week 24 | BSC-R | Baseline | 68.46 | Standard Deviation 15.63 | % of predicted |
| Efficacy: Mean Changes in FVC% Predicted From Baseline at Week 24 | Belumosudil-WC | Baseline | 69.73 | Standard Deviation 17.70 | % of predicted |
| Efficacy: Mean Changes in FVC% Predicted From Baseline at Week 24 | BSC-NC | Baseline | 68.46 | Standard Deviation 15.63 | % of predicted |
| Efficacy: Mean Changes in FVC% Predicted From Baseline at Week 24 | Total | Baseline | 69.19 | Standard Deviation 16.71 | % of predicted |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02688647/results